Arteriovenous (AV) fistula creation is a foundational procedure within vascular surgery and nephrology designed to establish permanent vascular access for patients requiring long-term hemodialysis. When kidneys reach end-stage renal disease (ESRD), toxic metabolic waste products and excess fluid must be mechanically filtered from the bloodstream. Standard peripheral veins are too small and fragile to tolerate the high blood flow rates (typically 300 to 500 mL/min) required for effective hemodialysis circuit circulation. By connecting a high-pressure, high-flow artery directly to a nearby superficial vein, arterial blood enters the vein directly. Over several weeks to months, this increased pressure and volume cause the vein wall to undergo thick-walled remodeling (vascular hypertrophy) and enlargement. Once matured, this enlarged vein can withstand repeated large-bore needle cannulations three times per week without collapsing or developing severe tissue damage. The primary goal of AV fistula creation is to provide a low-complication, long-lasting access site that minimizes systemic infection rates and maximizes patient survival on renal replacement therapy.

AV fistula creation is performed in an operating room or endovascular suite. The patient is placed in the supine position with the designated arm extended on an armboard. After sterile prepping and draping, regional nerve block (such as a brachial plexus block) or local anesthesia with intravenous sedation is administered. A 3 to 5 cm skin incision is made over the pre-operatively mapped artery and vein (e.g., at the wrist for a radiocephalic fistula or at the elbow crease for a brachiocephalic fistula). The target artery and vein are dissected free from surrounding tissues and mobilized. Small vascular clamps or vessel loops are applied to temporarily stop blood flow. A longitudinal arteriotomy and venotomy are performed. The vein end is either cut and joined to the side of the artery (end-to-side anastomosis) or both vessels are joined side-to-side using fine, non-absorbable monofilament sutures (such as 6-0 or 7-0 polypropylene). Clamps are released, and immediate blood flow through the newly formed connection is confirmed by visual inspection, Doppler probe assessment, and manual palpation of a continuous thrill. Hemostasis is verified, and the incision is closed in layers with absorbable sutures and sterile skin dressings.

Clinical evidence consistently demonstrates that mature autogenous AV fistulas provide superior clinical outcomes compared to alternative hemodialysis access modalities:

• Lower Infection Rates: According to the European Society for Vascular Surgery (ESVS) guidelines, native AV fistulas carry a significantly lower incidence of systemic bacteremia and access infections compared to prosthetic arteriovenous grafts (AVGs) and tunneled central venous catheters (CVCs).
• Superior Long-Term Patency: Mature native fistulas exhibit higher overall long-term patency rates, often functioning effectively for 5 to 10 years or longer with lower rates of repeated intervention compared to synthetic materials.
• Reduced Thrombosis Risk: Endogenous vascular endothelium possesses intrinsic antithrombotic properties, leading to lower rates of spontaneous access clotting compared to synthetic PTFE grafts.
• Lower Mortality and Morbidity: Extensive epidemiological data from the US Renal Data System (USRDS) demonstrate that patients receiving hemodialysis via a mature AV fistula experience lower all-cause mortality and fewer cardiovascular hospitalizations compared to catheter-dependent patients.
• Higher Quality Dialysis Delivery: High blood flow capabilities allow for optimized urea clearance rates (Kt/V), improving the clinical efficacy of each hemodialysis session.

Recovery following AV fistula creation involves both immediate surgical wound healing and a longer physiological vascular maturation phase:

• Post-Operative Days 1–14: Focuses on surgical incision healing, edema reduction, and pain control. Minor bruising and light swelling are expected. Sutures or staples are typically removed at 10 to 14 days if non-absorbable materials were used. Hand elevation is recommended to reduce post-operative edema.
• Weeks 2–6 (Early Maturation): Once skin incisions are fully healed, patients initiate isometric hand and forearm exercises (such as squeezing a rubber ball with a light tourniquet) to increase arterial blood flow and stimulate venous dilation. Clinical evaluation assesses the progression of the palpable thrill.
• Weeks 6–12 (Maturation Confirmation): Formal clinical and sonographic assessment is performed. A duplex ultrasound evaluates venous lumen diameter (target ≥6 mm), depth (target ≤6 mm), and blood flow rate (target ≥600 mL/min). If maturation is delayed, endovascular interventions such as balloon angioplasty may be performed to assist maturation.
• Long-Term Maintenance: Mature fistulas require daily self-inspection (palpating for thrill, listening for bruit) and avoidance of restrictive clothing, blood pressure cuffs, or venipunctures on the access arm.

AV fistula creation is indicated for the management and surgical treatment of:

• End-Stage Renal Disease (ESRD / CKD Stage 5): Patients with severe, irreversible kidney failure requiring permanent maintenance hemodialysis.
• Advanced Chronic Kidney Disease (CKD Stage 4): Patients with a estimated glomerular filtration rate (eGFR) below 15–20 mL/min/1.73m² who are projected to require hemodialysis within 6 to 12 months.
• Failing Arteriovenous Grafts (AVG): Patients with existing synthetic vascular grafts experiencing recurrent thrombosis, infection, or vascular degeneration requiring conversion to native access.
• Catheter-Dependent Dialysis Patients: Patients currently using tunneled central venous catheters (CVCs) who require transition to a lower-risk permanent vascular access to prevent catheter-related bloodstream infections and central venous stenosis.

Pre-procedure preparation requires a thorough clinical and anatomical evaluation starting several months prior to planned dialysis initiation. Patients undergo vessel mapping via high-resolution duplex ultrasound to evaluate the internal diameter, continuity, and patency of both superficial veins (cephalic and basilic) and deep arteries (radial and brachial) in both upper extremities. Veins must typically display an uninflated luminal diameter of at least 2.0 to 2.5 mm to be considered suitable for surgical reconstruction. Patients are counseled on vein preservation protocols, which strictly prohibit venipuncture, peripheral intravenous line insertion, and blood pressure measurements in the designated arm. Routine pre-operative lab work includes complete blood count, coagulation profile, basic metabolic panel, and blood typing. Medications influencing hemostasis, such as antiplatelet agents or anticoagulants, are managed according to surgical guidelines in consultation with the prescribing physician. Patients fast for 6 to 8 hours prior to surgery if conscious sedation or regional anesthesia is planned.

Complications of AV fistula creation can be categorized by onset and severity. Primary non-maturation occurs in 20% to 40% of cases, where the vein fails to enlarge or develop adequate blood flow, often due to underlying arterial stiffness or venous juxta-anastomotic stenosis. Early or late thrombosis (clotting) can lead to access loss, requiring endovascular thrombectomy or surgical revision. Dialysis Access-Associated Ischemic Steal Syndrome (HAISS) occurs when blood flow is diverted away from the lower arm and hand into the low-resistance fistula circuit, resulting in extremity pain, coldness, numbness, or tissue ischemia; severe cases require surgical flow reduction or ligation. Vascular steal or high output cardiac failure can occur in large proximal (brachial-based) fistulas due to excessive venous return increasing cardiac workload. Local complications include surgical site infection, wound hematoma, pseudoaneurysm formation from repeated needle punctures in the same site, and venous hypertension causing distal limb swelling.

The clinical journey for AV fistula creation begins months prior to the initiation of hemodialysis, typically when a patient reaches advanced Chronic Kidney Disease (CKD Stage 4 or 5). Vascular planning starts with a detailed physical exam and non-invasive vessel mapping using high-resolution duplex ultrasound to identify suitable arteries and veins. Once an optimal surgical site is selected—preferring the most distal location on the non-dominant arm—the patient undergoes pre-operative blood tests and cardiac risk assessment. The surgical procedure is performed as an outpatient or day-case surgery under local, regional (brachial plexus block), or light general anesthesia, taking approximately 60 to 90 minutes. Patients are monitored in recovery for a few hours and discharged home the same day with wound care instructions. The critical post-operative phase involves a 6 to 12-week maturation period, during which the patient performs hand-squeezing exercises to encourage vein dilatation. Maturation is routinely evaluated via serial ultrasound and physical assessment for the presence of a palpable "thrill" and auditory "bruit." Cannulation for dialysis begins only after the fistula meets strict clinical maturation criteria, followed by routine long-term surveillance by the multidisciplinary vascular and nephrology team.